Emerade has been developed by Namtall AB (Text in Swedish). Namtall AB is 100% focused on anaphylaxis treatment.
The company is lead by:
Namtall is a product development company of Medeca Pharma AB. Medeca is a Swedish pharmaceutical company, which has specialised in allergy and dermatology since 1991. Medeca introduced the first breathing dust mite covers on the European market and offers allergy tests and therapeutic clothing for atopic dermatitis.
Medeca´s main markets are Sweden, Denmark, Norway and Finland and it is now expanding its business to the UK, Germany and other European countries.
Please contact us if you have any questions.
Best regards,
Ingegerd Larsson,
Managing Director